- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 40/15 - Lymphocytes NK [natural-killer]Lymphocytes NKT [natural-killer T]
Détention brevets de la classe A61K 40/15
Brevets de cette classe: 118
Historique des publications depuis 10 ans
|
0
|
1
|
0
|
4
|
5
|
11
|
4
|
5
|
3
|
66
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immunitybio, Inc. | 369 |
5 |
| Board of Regents, The University of Texas System | 5782 |
4 |
| Takeda Pharmaceutical Company Limited | 2714 |
4 |
| Memorial Sloan-Kettering Cancer Center | 1925 |
3 |
| Oslo Universitetssykehus HF | 188 |
3 |
| Sloan-Kettering Institute for Cancer Research | 517 |
3 |
| Memorial Hospital for Cancer and Allied Diseases | 289 |
3 |
| The Regents of the University of California | 19887 |
2 |
| Dana-Farber Cancer Institute, Inc. | 2562 |
2 |
| FATE Therapeutics, Inc. | 203 |
2 |
| Imperial College Innovations Limited | 583 |
2 |
| Nantbio, Inc. | 138 |
2 |
| Research Institute at Nationwide Children's Hospital | 558 |
2 |
| University of Central Florida Research Foundation, Inc. | 1177 |
2 |
| Gaia Biomedicine Inc. | 32 |
2 |
| The Johns Hopkins University | 5662 |
1 |
| The General Hospital Corporation | 4724 |
1 |
| Duke University | 3065 |
1 |
| Bar-Ilan University | 427 |
1 |
| Board of Trustees of Michigan State University | 1183 |
1 |
| Autres propriétaires | 72 |